Small is promising when it comes to illuminating tiny tumors or precisely delivering drugs, but many worry about the safety of nano-scale materials. Now a team of scientists has created miniscule flakes of silicon that glow brightly, last long enough to slowly release cancer drugs, then break down into harmless by-products.
Since it first aired on Texas PBS stations two years ago, the documentary series State of Tomorrow™, produced by the University of Texas Foundation and Alpheus Media has garnered five National Association of Television Arts and Sciences Lone Star EMMY® awards and has been distributed with a special curriculum to every public school district in the stat
Vikram Juneja, a UC San Diego senior, has been named the first Churchill Scholar at the university and he will use the $50,000 award to complete a one-year graduate program at Cambridge University, where he will work on a master's thesis on cancer stem cell research.
Matthew Doty, assistant professor in the Department of Materials Science and Engineering at the University of Delaware, has received a National Science Foundation Faculty Early Career Development Award for his work on quantum dot molecules.
For millions of Americans with cancer, the side effects of chemotherapy and other treatment drugs can be devastating. But new drug-delivery research based on nano- and microtechnology from Tel Aviv University might provide much-needed relief, as well as more effective cancer treatment.
Piercell is proud to add Dr. Cyril Cohen to its scientific advisory board. Dr. Cohen, Head of the Laboratory of Tumor Immunology and Immunotherapy at the Bar-Ilan University in Israel is an immunotherapy expert with an e...
The World's Largest Nanotechnology Exhibition, nano tech 2009 International Nanotechnology Exhibition + Conference will be held from February 18 to 20, 2009 at Tokyo Big Sight, Tokyo (Japan). The eighth edition of th...
Brightly glowing nanoparticles known as "Cornell dots" are a safe, effective way to "light up" cancerous tumors so surgeons can find and remove them.
APR Applied Pharma Research s.a. ("APR") announces the acquisition of a new platform technology consisting of a patented Nanocoating process for the preparation of new patent protected biotechnology products fo...
One of the problems in the treatment of cancers continues to be the lack of ability when it comes to discriminating between healthy and unhealthy cells, with the result being that all cells are affected non-specifically ...
Terms
While we only use edited and approved content for Azthena
answers, it may on occasions provide incorrect responses.
Please confirm any data provided with the related suppliers or
authors. We do not provide medical advice, if you search for
medical information you must always consult a medical
professional before acting on any information provided.
Your questions, but not your email details will be shared with
OpenAI and retained for 30 days in accordance with their
privacy principles.
Please do not ask questions that use sensitive or confidential
information.
Read the full Terms & Conditions.